{"Title": "Controlling hepatitis C with simeprevir", "Year": 2015, "Source": "Lancet Infect. Dis.", "Volume": "15", "Issue": 1, "Art.No": null, "PageStart": 2, "PageEnd": 4, "CitedBy": 1, "DOI": "10.1016/S1473-3099(14)71048-5", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84918508488&origin=inward", "Abstract": null, "AuthorKeywords": null, "IndexKeywords": ["Antiviral Agents", "Female", "Hepacivirus", "Hepatitis C, Chronic", "Heterocyclic Compounds, 3-Ring", "Humans", "Interferon-alpha", "Male", "Oligopeptides", "Polyethylene Glycols", "Recombinant Proteins", "Ribavirin", "Sulfonamides"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 0, "EID": "2-s2.0-84918508488", "SubjectAreas": [["Infectious Diseases", "MEDI", "2725"]], "AuthorData": {"7006885162": {"Name": "Dusheiko G.", "AuthorID": "7006885162", "AffiliationID": "60032819, 60022148", "AffiliationName": "UCL Institute of Liver and Digestive Health and Royal Free Hospital"}}}